Retail sales of weight management products in
the UK declined by 2% in current value terms in 2011, to £126 million.
The sharp slump of GlaxoSmithKline Plc’s OTC obesity pill Alli (value
sales decline of 20%) had a major impact on the category. Excluding
Alli’s OTC obesity, weight management enjoyed current value growth of 3%
in 2011. This reflects a feeling expressed in trade interviews that
notwithstanding its more recent loss of market credibility, the product
has helped to attract new.
Euromonitor International''s Weight Management in United Kingdom report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Product coverage: Meal Replacement Slimming, OTC Obesity, Other Slimming Products, Slimming Teas, Weight Loss Supplements.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Weight Management market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years'' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Euromonitor International''s Weight Management in United Kingdom report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Product coverage: Meal Replacement Slimming, OTC Obesity, Other Slimming Products, Slimming Teas, Weight Loss Supplements.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Weight Management market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years'' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
United Kingdom Weight Management Industry
Published: June 2012 No. of Pages: 30 Price: US $ 900
Table of Contents
Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Weight Management: Value 2006-2011
Table 2 Sales of Weight Management: % Value Growth 2006-2011
Table 3 Weight Management Company Shares 2007-2011
Table 4 Weight Management Brand Shares 2008-2011
Table 5 Forecast Sales of Weight Management: Value 2011-2016
Table 6 Forecast Sales of Weight Management: % Value Growth 2011-2016
GlaxoSmithKline Plc in Consumer Health (united Kingdom)
Strategic Direction
Key Facts
Summary 1 GlaxoSmithKline Plc: Key Facts
Company Background
Production
Competitive Positioning
Summary 2 GlaxoSmithKline Plc: Competitive Position 2011
Executive Summary
Growth Despite Tough Trading Conditions and Policy Uncertainty
Sports Nutrition Hits the Mainstream While Other Categories Return To the Margins
Innovation the Key for Brands To Compete With Private Label
Supermarkets and Internet Retailing Gain Share But Specialists Fight Back
Growth Picks Up Marginally Over the Forecast Period
Key Trends and Developments
Opportunities for Growth in A Dire Economic Climate
Current Impact
Outlook
Future Impact
Innovation Key for Differentiation and Market Capture
the Days of Stellar Switches Are Over (for Now)
Uncertain Outlook for Traditional Herbal Products
Promoting Responsible Self-medication: Where Profit Meets Policy
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 8 Life Expectancy at Birth 2006-2011
Market Data
Table 9 Sales of Consumer Health by Category: Value 2006-2011
Table 10 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 11 Consumer Health Company Shares 2007-2011
Table 12 Consumer Health Brand Shares 2008-2011
Table 13 Penetration of Private Label by Category 2006-2011
Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 16 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
EU Legislation
UK Environment
Self-medication/self-care and Preventative Medicine
Switches
Summary 3 OTC Switches 2009-2011
Sources
Summary 4 Research Sources
Published: June 2012 No. of Pages: 30 Price: US $ 900
Table of Contents
Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Weight Management: Value 2006-2011
Table 2 Sales of Weight Management: % Value Growth 2006-2011
Table 3 Weight Management Company Shares 2007-2011
Table 4 Weight Management Brand Shares 2008-2011
Table 5 Forecast Sales of Weight Management: Value 2011-2016
Table 6 Forecast Sales of Weight Management: % Value Growth 2011-2016
GlaxoSmithKline Plc in Consumer Health (united Kingdom)
Strategic Direction
Key Facts
Summary 1 GlaxoSmithKline Plc: Key Facts
Company Background
Production
Competitive Positioning
Summary 2 GlaxoSmithKline Plc: Competitive Position 2011
Executive Summary
Growth Despite Tough Trading Conditions and Policy Uncertainty
Sports Nutrition Hits the Mainstream While Other Categories Return To the Margins
Innovation the Key for Brands To Compete With Private Label
Supermarkets and Internet Retailing Gain Share But Specialists Fight Back
Growth Picks Up Marginally Over the Forecast Period
Key Trends and Developments
Opportunities for Growth in A Dire Economic Climate
Current Impact
Outlook
Future Impact
Innovation Key for Differentiation and Market Capture
the Days of Stellar Switches Are Over (for Now)
Uncertain Outlook for Traditional Herbal Products
Promoting Responsible Self-medication: Where Profit Meets Policy
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 8 Life Expectancy at Birth 2006-2011
Market Data
Table 9 Sales of Consumer Health by Category: Value 2006-2011
Table 10 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 11 Consumer Health Company Shares 2007-2011
Table 12 Consumer Health Brand Shares 2008-2011
Table 13 Penetration of Private Label by Category 2006-2011
Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 16 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
EU Legislation
UK Environment
Self-medication/self-care and Preventative Medicine
Switches
Summary 3 OTC Switches 2009-2011
Sources
Summary 4 Research Sources
No comments:
Post a Comment